GRIN2A and epilepsy: The next most promising candidate gene for CAS was GRIN2A, which is also associated with the epilepsy-aphasia syndromes, now termed developmental and/or epileptic encephalopathy with spike-wave activation in sleep [16], and including Llandau-Kleffner syndrome [17–19].